Clinical issues. Transfusion safety: what has been done; what is still needed?
MR Brown, MG Fritsma… - MLO: Medical Laboratory …, 2005 - search.ebscohost.com
… Fritsma, MA, MT(ASCP) SBB; … G) — and gel and solid phase technologies have
enhanced the ahilit\' of transfusion scn'ices to identify red-cell antibodies in patients serum …
enhanced the ahilit\' of transfusion scn'ices to identify red-cell antibodies in patients serum …
[PDF][PDF] Use of blood products and factor concentrates for coagulation therapy
MG Fritsma - Clinical Laboratory Science, 2003 - clsjournal.ascls.org
… MARGARET G FRITSMA … Margaret G Fritsma MA MT(ASCP) SBB is Associate Profes- …
Address for correspondence: Margaret G Fritsma MA MT (ASCP) SBB, Associate Professor, …
Address for correspondence: Margaret G Fritsma MA MT (ASCP) SBB, Associate Professor, …
[PDF][PDF] Hitting the target with antithrombotic therapy
MG Fritsma, BF Rodak - MEDICAL LABORATORY OBSERVER, 2007 - researchgate.net
Anticoagulants or antithrombotics, known to the public as “blood thinners” have been used
successfully since the 1940s to reduce secondary thrombus formation. 1 Although they do not …
successfully since the 1940s to reduce secondary thrombus formation. 1 Although they do not …
[PDF][PDF] 37 Normal Hemostasis and Coagulation
MG Fritsma, GA Fritsma - vip. persianss. ir - academia.edu
1. List the systems that interact to provide hemostasis. 2. Describe the properties of the
vascular intima in the initiation and regulation of hemostasis and fibrinolysis. 3. List the …
vascular intima in the initiation and regulation of hemostasis and fibrinolysis. 3. List the …
Transfusion safety: What has been done; What is still nppripri?
MR Brown, MG Fritsma… - Medical Laboratory …, 2005 - search.ebscohost.com
The article discusses the issue of blood transfusion safety. Transfusion safety is different
from blood component safety in such a way that blood safety revolves around ensuring a low …
from blood component safety in such a way that blood safety revolves around ensuring a low …
Do EDTA Tubes Cross-Contaminate Gel Separator Tubes?
LT Cooper, MG Fritsma, MB Marques… - Clinical Laboratory …, 2004 - search.proquest.com
The purpose of this study was to determine if cross-contamination occurs when an EDTA
collection tube is drawn immediately before a gel separator tube. This study intends to support …
collection tube is drawn immediately before a gel separator tube. This study intends to support …
Clinical Correlations: A Course Designed to Interconnect Clinical Laboratory Science
MG Fritsma, LH Jeff - Clinical Laboratory Science, 2004 - search.proquest.com
It is often difficult for CLS students to integrate disciplinespecific clinical and technical
knowledge, as well as education, management, and research skills. We developed a course, …
knowledge, as well as education, management, and research skills. We developed a course, …
Do Clot Activator Tubes Cross-Contaminate Citrate Tubes?
BV Miller, LT Cooper, MG Fritsma… - Clinical Laboratory …, 2004 - search.proquest.com
The purpose of this study was to determine if cross-contamination occurs when a clot
activator (gel separator) collection tube is drawn immediately before a 3.2% sodium citrate (…
activator (gel separator) collection tube is drawn immediately before a 3.2% sodium citrate (…
[PDF][PDF] Managing the bleeding patient
GA Fritsma - Clinical Laboratory Science, 2003 - clsjournal.ascls.org
… Please refer to the accompanying article in this issue by Margaret G Fritsma, “Use of Blood
Products and Factor Concentrates for Coagulation Therapy” for a discussion of the use of …
Products and Factor Concentrates for Coagulation Therapy” for a discussion of the use of …
NCA and BOR consider new credentialing agency
GA Fritsma - Clinical Laboratory Science, 2006 - go.gale.com
NCA was chartered in 1978 as a peer-review credentialing agency in response to concerns
for pathologists' control of the clinical laboratory science (CLS) profession and has …
for pathologists' control of the clinical laboratory science (CLS) profession and has …